Quantcast

Cosmederm Signs Licensing and Distribution Agreement With Dr Reddy’s

September 4, 2008

Cosmederm Technologies, a specialty pharmaceutical company focused on dermatology and aesthetic medicine, has signed a licensing and distribution agreement with Dr Reddy’s Laboratories.

The agreement grants Dr Reddy’s exclusive rights to distribute Cosmederm Technologies’s unique skin care products throughout India.

Cosmederm’s proprietary technology allows for the formulation of highly potent, non-irritating skin care products in the areas of anti-aging, acne, pruritus, rosacea and others. The partnership is for two product lines – Refinity peel kits (Glycolic acid 70%) and Cosmederm peel kits (Glycolic acid 50%).

Through this partnership Dr Reddy’s is said to enter the aesthetic dermatology segment and consolidates its position in cosmeceuticals.

Sean Edwards, president of Cosmederm Technologies, said: “The opportunity to work with Dr Reddy’s and introduce our products to Indian consumers is a great milestone for Cosmederm. As a global brand, Dr Reddy’s is a very valuable partner.”




comments powered by Disqus